1Chen C, Guo SM, Liu. B. A randomized controlled trial of kurorimese versus interferon- alpha 2a treatment in patients with chronic hepatitis B.J Viral hepat,2000;7:225
2Lampertico P,Del - Ninno E,Maszin A,et al.A randomized,controlled trial of a 24 month course of interferon alpha 2b in patient with chronic hepatitis B who had hepatitis virus DNA without hepatitis B e antigen in serum. Hepatology, 1997;26:1621
3Fernandez I, Castellano G, Manzano. ML, et al. Twelvemonth interferon - alpha therapy induces a similar sustained response in anti - HBe positive and HBeAg - positive chronic hepatitis B patients. Hepatogastroenterology. 2000;47:1351
4Boyer N, Marcelin P. Pegylated interferon:new progress in treatment for chronic hepatitis C. Gastroenterol Clin Biol. 2000;24: 767
5Angelico M,Paolo DD,Palmieri G,et al. Lamivudine inproves the Child - Pugh score in HBsAg positive patients lised for liver transplantation. Gastroenterology, 2000; 118: A 1422
6Rizzetto M, Volpes, R Smedile A. Response of pre - core mutant chronic hepatitis B infection to lamivudine. J Med Virol. 2000; 61: 398
7Santantonio T, Mazzola M. Miglietta. A, et al. Long - term follow - up of patients with anti - HBe/HBV DNA - positive chronic hepatitis B treated for 12 month with lamivudine. J Hepatol, 2000; 32: 300
8Dimou E, Papatheodorisdis GV, Lara A, et al. dEfficacy of long - term lamicudine monotheragy in HBeAg megative chronic hepatitis B. Antivir Ther, 2000; 5(suppl 1 ) :44.
9Tassopoulos NC, Anagnostopoulus GD. Long- term lamivudine treatment of patients with precore mutant profile(HBeAg( - )/anti HBe( + ))chronic hepatotos B. Antivir Ther, 2000;5(suppl1)):34
10Yeh CT, Chien KN ,Chu CM, et al. Chearance of the original hepatitis B virus YMDD - motifmutants with emergence of distinct lamivudine - rsistant mutants during prolonged lamivudine therapy. Hipatology, 2000; 31: 1318
